These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 2693655)

  • 1. Possible mechanism for the renoprotective effect of angiotensin converting enzyme inhibitors.
    Raij L; Shultz PJ; Tolins JP
    J Hypertens Suppl; 1989 Sep; 7(7):S33-6; discussion S36-7. PubMed ID: 2693655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blocking angiotensin II ameliorates proteinuria and glomerular lesions in progressive mesangioproliferative glomerulonephritis.
    Nakamura T; Obata J; Kimura H; Ohno S; Yoshida Y; Kawachi H; Shimizu F
    Kidney Int; 1999 Mar; 55(3):877-89. PubMed ID: 10027924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The effect of angiotensin-converting enzyme inhibitors on the progression of chronic renal failure].
    Bernadet-Monrozies P; Rostaing L; Kamar N; Durand D
    Presse Med; 2002 Nov; 31(36):1714-20. PubMed ID: 12467154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antihypertensive therapy and the progression of renal disease.
    Anderson S
    J Hypertens Suppl; 1989 Sep; 7(7):S39-42. PubMed ID: 2693656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of hypertensive glomerular injury.
    Tolins JP; Shultz P; Raij L
    Am J Cardiol; 1988 Oct; 62(11):54G-58G. PubMed ID: 3051996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiotensin-converting enzyme inhibition and renal protection. An assessment of implications for therapy.
    Hollenberg NK; Raij L
    Arch Intern Med; 1993 Nov; 153(21):2426-35. PubMed ID: 8215747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiotensin-converting enzyme inhibitors in chronic renal failure.
    Opsahl JA; Abraham PA; Keane WF
    Drugs; 1990; 39 Suppl 2():23-32. PubMed ID: 2188823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of angiotensin II on the kidney: does an angiotensin II receptor blocker make sense?
    Hollenberg NK
    Am J Kidney Dis; 2000 Sep; 36(3 Suppl 1):S18-23. PubMed ID: 10986155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The renoprotective properties of angiotensin-converting enzyme inhibitors in a chronic model of membranous nephropathy are solely due to the inhibition of angiotensin II: evidence based on comparative studies with a receptor antagonist.
    Zoja C; Donadelli R; Corna D; Testa D; Facchinetti D; Maffi R; Luzzana E; Colosio V; Bertani T; Remuzzi G
    Am J Kidney Dis; 1997 Feb; 29(2):254-64. PubMed ID: 9016898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal protective effects of angiotensin converting enzyme inhibitors.
    Weder AB
    Am J Hypertens; 1990 Nov; 3(11):273S-277S. PubMed ID: 2261145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Slowing the progression of chronic renal insufficiency with captopril in rats with spontaneous arterial hypertension and adriamycin nephropathy].
    Jovanović DB; Jovović Dj; Varagić J; Dimitrijević J; Dragojlović Z; Djukanović L
    Srp Arh Celok Lek; 2002; 130(3-4):73-80. PubMed ID: 12154518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin II and its receptors in the diabetic kidney.
    Burns KD
    Am J Kidney Dis; 2000 Sep; 36(3):449-67. PubMed ID: 10977776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Control of blood pressure by the renin-angiotensin-aldosterone system.
    Hall JE
    Clin Cardiol; 1991 Aug; 14(8 Suppl 4):IV6-21; discussion IV51-5. PubMed ID: 1893644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of the renin-angiotensin system in the regulation of glomerular filtration.
    Sraer JD; Kanfer A; Rondeau E; Lacave R
    J Cardiovasc Pharmacol; 1989; 14 Suppl 4():S21-5. PubMed ID: 2483424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-protein diets and angiotensin-converting enzyme inhibition in progressive renal failure.
    Klahr S
    Am J Kidney Dis; 1993 Jul; 22(1):114-9. PubMed ID: 8322773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of angiotensin-converting enzyme inhibitors and angiotensin-receptor blockers in the prevention of progression of renal disease.
    Ram CV; Vergne-Marini P
    Curr Hypertens Rep; 1999 Oct; 1(5):431-5. PubMed ID: 10981102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiotensin converting enzyme inhibitors and progression of chronic renal failure.
    Tolins JP; Raij L
    Kidney Int Suppl; 1990 Nov; 30():S118-22. PubMed ID: 2259070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interactions of the endothelium and mesangium in glomerular injury.
    Sweeney C; Shultz P; Raij L
    J Am Soc Nephrol; 1990 Sep; 1(3 Suppl 1):S13-20. PubMed ID: 16989073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recommendations for the management of special populations: renal disease in diabetes.
    Raij L
    Am J Hypertens; 2003 Nov; 16(11 Pt 2):46S-49S. PubMed ID: 14625161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intrarenal renin-angiotensin system in renal physiology and pathophysiology.
    Johnston CI; Fabris B; Jandeleit K
    Kidney Int Suppl; 1993 Jul; 42():S59-63. PubMed ID: 8361131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.